cyclopentane has been researched along with Granulocytic Leukemia, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, X; Jin, Y; Li, J; Li, Y; Liu, C; Lu, Y; Nie, D; Pan, J; Zhou, J | 1 |
| Bahjat, M; Bende, RJ; Bloedjes, T; de Wilde, G; Eldering, E; Guikema, JEJ; Kersten, MJ; Luijks, DM; Maas, C; van Dam, T; van Noesel, CJM | 1 |
| Chiaro, C; Gandhi, UH; Hafer, KT; Hankey, P; Hegde, S; Kaushal, N; Kennett, MJ; Paulson, RF; Prabhu, KS; Ravindra, KC; Thompson, JT; van den Heuvel, JP | 1 |
| Barrett, AJ; Couriel, D; Dermime, S; Hensel, N; Jiang, YZ; Mavroudis, D; Molldrem, J | 1 |
4 other study(ies) available for cyclopentane and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells.
Topics: Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclopentanes; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Neoplastic Stem Cells; Point Mutation; Pyrimidines; Ubiquitin-Activating Enzymes | 2018 |
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors.
Topics: Apoptosis; Cell Line, Tumor; Cyclopentanes; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; S Phase Cell Cycle Checkpoints; Signal Transduction; Ubiquitin-Activating Enzymes | 2019 |
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Neoplastic Stem Cells; Prostaglandins; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Splenomegaly; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |
Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen.
Topics: Bone Marrow Transplantation; Brefeldin A; CD4-Positive T-Lymphocytes; Chloroquine; Cyclopentanes; Cytotoxicity, Immunologic; fas Receptor; Graft vs Host Reaction; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Synthesis Inhibitors | 1996 |